Back to HRTX
UBS Group AG HRTX Position History
Heron Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$29K
Q3 2026
Peak value
$3.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $12K |
| Q3 2025 | $3.7M |
| Q3 2025 | $6K |
| Q4 2025 | $13K |
| Q4 2025 | $2.7M |
| Q4 2025 | $47K |
| Q1 2026 | $9K |
| Q1 2026 | $1.8M |
| Q2 2026 | $6K |
| Q2 2026 | $1.3M |
| Q2 2026 | $9K |
| Q3 2026 | $2K |
| Q3 2026 | $627K |
| Q3 2026 | $3K |
| Q3 2026 | $29K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $29K | 91.1K | — | — |
| Q3 2026 | $3K | 8.8K | — | — |
| Q3 2026 | $627K | 2.00M | — | — |
| Q3 2026 | $2K | 7.0K | — | — |
| Q2 2026 | $9K | 21.7K | — | — |
| Q2 2026 | $1.3M | 2.96M | — | — |
| Q2 2026 | $6K | 14.0K | — | — |
| Q1 2026 | $1.8M | 2.27M | — | — |
| Q1 2026 | $9K | 11.7K | — | — |
| Q4 2025 | $47K | 36.5K | — | — |
| Q4 2025 | $2.7M | 2.05M | — | — |
| Q4 2025 | $13K | 9.8K | — | — |
| Q3 2025 | $6K | 4.4K | — | — |
| Q3 2025 | $3.7M | 2.92M | — | — |
| Q3 2025 | $12K | 9.8K | — | — |